Page last updated: 2024-10-27

flecainide and Ataxia

flecainide has been researched along with Ataxia in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, TF1
Garcia, RT1
Bui, JQ1
Thinda, A1
Amsterdam, EA1

Other Studies

1 other study available for flecainide and Ataxia

ArticleYear
Confused and Too Long: Neurotoxicity and Cardiac Toxicity of Flecainide.
    Critical pathways in cardiology, 2017, Volume: 16, Issue:1

    Topics: Aged; Anti-Arrhythmia Agents; Ataxia; Atrial Fibrillation; Atrioventricular Block; Cardiotoxicity; E

2017